| P2093 | author name string | Katherine D Crew | |
| | Gilad J Kuperman | |
| | Rita Kukafka | |
| | Alejandro Vanegas | |
| | Margaret Sin | |
| | Thomas B Silverman | |
| | Jill Dimond | |
| P2860 | cites work | Decision aids for people facing health treatment or screening decisions | Q24235817 |
| | Decision aids for people facing health treatment or screening decisions | Q24250303 |
| | Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success | Q24555737 |
| | Improving Decision Making about Genetic Testing in the Clinic: An Overview of Effective Knowledge Translation Interventions | Q26764748 |
| | Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO | Q26995389 |
| | "Many miles to go …": a systematic review of the implementation of patient decision support interventions into routine clinical practice | Q27005649 |
| | American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography | Q28295438 |
| | Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation | Q33633402 |
| | Effect of Arrangement of Stick Figures on Estimates of Proportion in Risk Graphics | Q33756473 |
| | Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality | Q34135443 |
| | Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study | Q34498634 |
| | Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group | Q34512590 |
| | Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study | Q34749278 |
| | Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature | Q35088283 |
| | Why Breast Cancer Risk by the Numbers Is Not Enough: Evaluation of a Decision Aid in Multi-Ethnic, Low-Numerate Women. | Q35922603 |
| | Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach. | Q35994562 |
| | Uptake rates for breast cancer genetic testing: a systematic review | Q36479647 |
| | Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral | Q36595729 |
| | Barriers and Facilitators to Patient-Provider Communication When Discussing Breast Cancer Risk to Aid in the Development of Decision Support Tools | Q36613582 |
| | A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer | Q36789430 |
| | The comprehensiveness of family cancer history assessments in primary care | Q36851863 |
| | Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging | Q36920323 |
| | Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers | Q37090813 |
| | Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer | Q37155253 |
| | Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization | Q37225176 |
| | A measure of informed choice. | Q37331258 |
| | Differential use of available genetic tests among primary care physicians in the United States: results of a national survey | Q37393205 |
| | Usability Testing of a Web-Based Decision Aid for Breast Cancer Risk Assessment Among Multi-Ethnic Women | Q37676534 |
| | Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers | Q38717239 |
| | Sociodemographic, psychosocial and clinical factors associated with uptake of genetic counselling for hereditary cancer: a systematic review | Q38958391 |
| | Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study | Q39992636 |
| | Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer. | Q40099482 |
| | Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. | Q43800820 |
| | Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer | Q44352161 |
| | Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians | Q45122532 |
| | Breast cancer risk communication: assessment of primary care physicians by standardized patients | Q49095608 |
| | Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement | Q54092157 |
| | The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample | Q59088124 |
| | Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group | Q73108544 |
| | BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model | Q81415321 |
| | Georgia Primary Care Providers' Knowledge of Hereditary Breast and Ovarian Cancer Syndrome | Q86857890 |
| P921 | main subject | decision making | Q1331926 |
| P304 | page(s) | 961-969 | |
| P577 | publication date | 2018-12-05 | |
| P1433 | published in | AMIA Annual Symposium proceedings | Q27720789 |
| P1476 | title | An Applied Framework in Support of Shared Decision Making about BRCA Genetic Testing | |
| P478 | volume | 2018 | |